Skip to Main Content

Browse issues

Pathogens and Disease Cover Image for Volume 82
Volume 82
2024
EISSN 2049-632X
Issue navigation

Volume 82, 2024

Priority Paper

Letícia Rampazzo da Gama Viveiro and others
Pathogens and Disease, Volume 82, 2024, ftae001, https://doi.org/10.1093/femspd/ftae001

Selective serotonin reuptake inhibitors (SSRIs) were active against Cryptococcus gattii and in combination with amphotericin B (AmB) exhibited a synergistic effect. Selective serotonin reuptake inhibitors (SSRIs) also reduced capsule size and biofilm, suggesting their potential in cryptococcosis treatments.

Minireviews

Zhe-Yu Peng and others
Pathogens and Disease, Volume 82, 2024, ftad036, https://doi.org/10.1093/femspd/ftad036

This review help readers fully understand the current progression of ZIKV vaccine and enhance the awareness of the prevention of ZIKV.

Omkar Indari and others
Pathogens and Disease, Volume 82, 2024, ftae002, https://doi.org/10.1093/femspd/ftae002

Several biological agents can reactivate the Epstein–Barr virus, with potential consequences for the human host.

Sara Ahmadi Badi and others
Pathogens and Disease, Volume 82, 2024, ftae005, https://doi.org/10.1093/femspd/ftae005

The authors discuss a new axis for hepcidin in liver fibrosis.

Muttiah Barathan
Pathogens and Disease, Volume 82, 2024, ftae006, https://doi.org/10.1093/femspd/ftae006

Unveiling Acute Undifferentiated Febrile Illness: Global Prevalence, Challenges, and One Health Strategies for Emerging Zoonotic Threats in Resource-Limited Settings.

Eva Vaňková and others
Pathogens and Disease, Volume 82, 2024, ftae007, https://doi.org/10.1093/femspd/ftae007

The use of a combination of non-thermal plasma and antibiotics against dangerous pathogens is a potential solution to the antimicrobial resistance crisis.

Feng-yuan Zhang and others
Pathogens and Disease, Volume 82, 2024, ftae003, https://doi.org/10.1093/femspd/ftae003

This review summarized in detail several factors of Candida albicans inducing macrophage pyroptosis, including hypha formation, cell wall remodeling, candidalysin, and so on, to help us better utilize macrophage pyroptosis, controlling candidal infection, and reduce unnecessary immune damage.

Héctor Serrano-Coll and others
Pathogens and Disease, Volume 82, 2024, ftae013, https://doi.org/10.1093/femspd/ftae013

Leprosy, a disabling disease, triggers inflammatory reactions affecting patients. Understanding these reactions is crucial for better treatment, but it's not well-known among healthcare workers caring for leprosy patients.

Taylor B Poston
Pathogens and Disease, Volume 82, 2024, ftae017, https://doi.org/10.1093/femspd/ftae017

This review summarizes recent developments in mucosal and Chlamydia immunity applicable to Chlamydia vaccine design.

Jeffrey R Reitano and Jörn Coers
Pathogens and Disease, Volume 82, 2024, ftae019, https://doi.org/10.1093/femspd/ftae019

This review will discuss a single branch of the immune system, so-called “cell-autonomous immunity” and how it is counteracted by Chlamydia species.

Mohammad Raguib Munif and others
Pathogens and Disease, Volume 82, 2024, ftae024, https://doi.org/10.1093/femspd/ftae024

In this review, we provide contemporary evidence of the most plausible mechanisms associated with the development of PSGN and highlight future avenues for research.

Yunqi Mi and others
Pathogens and Disease, Volume 82, 2024, ftae022, https://doi.org/10.1093/femspd/ftae022

The review focuses on the global distribution, molecular biology, viral life cycle, host range and transmissibility, and antiviral natural products development of JEV.

Hanna Marti and others
Pathogens and Disease, Volume 82, 2024, ftae030, https://doi.org/10.1093/femspd/ftae030

This article focuses on an update on zoonotic and other veterinary chlamydiae and their genetic manipulation.

Research Articles

Mélanie Gonzales and others
Pathogens and Disease, Volume 82, 2024, ftae009, https://doi.org/10.1093/femspd/ftae009

Disrupting quorum sensing as a promising alternative to conventional antimicrobials as part of the One Health initiative.

Puck B van Kasteren and others
Pathogens and Disease, Volume 82, 2024, ftae010, https://doi.org/10.1093/femspd/ftae010

Respiratory pathogen prevalence in the general population differs between young children and (older) adults and nasal proinflammatory cytokine concentrations associate with the presence of (mild) symptoms of respiratory infection.

Ashlesh K Murthy and others
Pathogens and Disease, Volume 82, 2024, ftae008, https://doi.org/10.1093/femspd/ftae008

Protective anti-chlamydial vaccine regimens induce Ag-specific CD4+ T cell response that mediates early inhibition of pathogenic CD8+ T cell response following challenge and may serve as a predictive biomarker of protection against Chlamydia -induced chronic pathologies.

Charlotte Abell-King and others
Pathogens and Disease, Volume 82, 2024, ftae012, https://doi.org/10.1093/femspd/ftae012

Bacterial multi-species invasion of human host cells. UPEC in Orange, Enterococcus facials in green.

Rajnish Sahu and others
Pathogens and Disease, Volume 82, 2024, ftae004, https://doi.org/10.1093/femspd/ftae004

Chlamydia nanovaccine development and optimization of immunization routes.

Chuanzhi Zhu and others
Pathogens and Disease, Volume 82, 2024, ftae014, https://doi.org/10.1093/femspd/ftae014

This study delves into the genomic features of a novel attenuated Mycobacterium tuberculosis strain, cultivated for a long period, elucidating its immune response at cellular and in vivo levels. These insights advance tuberculosis pathogenesis understanding and vaccine development.

Shan Cheng and others
Pathogens and Disease, Volume 82, 2024, ftae011, https://doi.org/10.1093/femspd/ftae011

Chlamydia trachomatis-induced autophagy is regulated via the CYTOR/miR-206/MAPK1 axis.

Tayhlor Tanner and others
Pathogens and Disease, Volume 82, 2024, ftae015, https://doi.org/10.1093/femspd/ftae015

This paper significantly contributes to Chlamydia vaccine research by analyzing the immunogenicity of a novel antigen, MECA, through computational modeling and in vivo validation, offering valuable insights to vaccine development.

Helene May and others
Pathogens and Disease, Volume 82, 2024, ftae016, https://doi.org/10.1093/femspd/ftae016

Sphingosine directly targets and kills extra- and intracellular bacteria.

David R Thomas and others
Pathogens and Disease, Volume 82, 2024, ftae018, https://doi.org/10.1093/femspd/ftae018

Using genetic mutants, it was shown that a novel Coxiella burnetii protein does not influence the ability of the bacterium to replicate inside eukaryotic cells but does impact a key feature of the space within which the bacteria replicate.

Yuan Wei and others
Pathogens and Disease, Volume 82, 2024, ftae020, https://doi.org/10.1093/femspd/ftae020

Observation of IF staining of MA104 N*V cells 48 h after infection with Chlamydia trachomatis.

Nabia Shahreen and others
Pathogens and Disease, Volume 82, 2024, ftae023, https://doi.org/10.1093/femspd/ftae023

The article reveals that optimal protein allocation is key to understanding Neisseria gonorrhoeae’s metabolism, impacting critical enzymes and energy production pathways.

Jenane Konesan and others
Pathogens and Disease, Volume 82, 2024, ftae026, https://doi.org/10.1093/femspd/ftae026

This study reveals that Uropathogenic Escherichia coli causes significant damage to bladder mucosa, affecting cell integrity, barrier function and contractility, highlighting the potential role of serotonin in bladder infections.

Sanaz Rastegar and others
Pathogens and Disease, Volume 82, 2024, ftae028, https://doi.org/10.1093/femspd/ftae028

A novel bacteriophage was isolated from hospital wastewater; its genome was analyzed, and when tested with antibiotics, it showed effective results against an MDR A. baumannii. This study could help with treatments for infections.

Jiaqi Liu and others
Pathogens and Disease, Volume 82, 2024, ftae027, https://doi.org/10.1093/femspd/ftae027

The rDEV–Pmp17G vaccine was alternative to the major outer membrane protein (MOMP) vaccine against waterflow Chlamydia psittaci infection. Moreover, it was a novel approach for combating chlamydia transmission from animals to humans.

Agnieszka Razim and others
Pathogens and Disease, Volume 82, 2024, ftae025, https://doi.org/10.1093/femspd/ftae025

Manuscript shows possible sources of cross-reactivity of pre-pandemic sera with SARS-CoV-2 proteins.

Fatemeh Sanjar and others
Pathogens and Disease, Volume 82, 2024, ftae021, https://doi.org/10.1093/femspd/ftae021

We have performed phylogenetic analysis and defined genotypic features of burn-wound-associated Pseudomonas aeruginosa isolated from burn patients during hospitalization. These burn-wound strains revealed polyclonal infection of some patients while other infections consisted of a clonal infection evolving over time.

Tesfaye Belay and others
Pathogens and Disease, Volume 82, 2024, ftae029, https://doi.org/10.1093/femspd/ftae029

Deficiency in a receptor leads to a reduced disease of chlamydia in a mouse model.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close